163 related articles for article (PubMed ID: 24977435)
1. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
Lutz CT
Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
[TBL] [Abstract][Full Text] [Related]
2. The interaction of KIR3DL1*001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope.
Saunders PM; Vivian JP; Baschuk N; Beddoe T; Widjaja J; O'Connor GM; Hitchen C; Pymm P; Andrews DM; Gras S; McVicar DW; Rossjohn J; Brooks AG
J Immunol; 2015 Jan; 194(2):781-789. PubMed ID: 25480565
[TBL] [Abstract][Full Text] [Related]
3. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
[TBL] [Abstract][Full Text] [Related]
4. Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1.
Sanjanwala B; Draghi M; Norman PJ; Guethlein LA; Parham P
J Immunol; 2008 Nov; 181(9):6293-300. PubMed ID: 18941220
[TBL] [Abstract][Full Text] [Related]
5. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
[TBL] [Abstract][Full Text] [Related]
6. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
[TBL] [Abstract][Full Text] [Related]
7. Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction.
Grifoni A; Montesano C; Patronov A; Colizzi V; Amicosante M
Biomed Res Int; 2013; 2013():283805. PubMed ID: 23984333
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
[TBL] [Abstract][Full Text] [Related]
9. Effect of Bw4 and Bw6 epitope mismatches on antibody production, acute and chronic rejection, and graft survival in renal allografts.
Leffell MS; Kraus E; Racusen LC; Ratner LE; Charney D; Zachary AA
Transplantation; 2001 Aug; 72(3):433-7. PubMed ID: 11502972
[TBL] [Abstract][Full Text] [Related]
10. Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity.
O'Connor GM; Vivian JP; Widjaja JM; Bridgeman JS; Gostick E; Lafont BA; Anderson SK; Price DA; Brooks AG; Rossjohn J; McVicar DW
J Immunol; 2014 Mar; 192(6):2875-84. PubMed ID: 24563253
[TBL] [Abstract][Full Text] [Related]
11. Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.
Vyas Y; Selvakumar A; Steffens U; Dupont B
Tissue Antigens; 1998 Dec; 52(6):510-9. PubMed ID: 9894849
[TBL] [Abstract][Full Text] [Related]
12. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
[TBL] [Abstract][Full Text] [Related]
13. KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in
Zhang X; Lu X; Moog C; Yuan L; Liu Z; Li Z; Xia W; Zhou Y; Wu H; Zhang T; Su B
Front Immunol; 2018; 9():1855. PubMed ID: 30147699
[No Abstract] [Full Text] [Related]
14. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
15. Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells.
O'Connor GM; Guinan KJ; Cunningham RT; Middleton D; Parham P; Gardiner CM
J Immunol; 2007 Jan; 178(1):235-41. PubMed ID: 17182560
[TBL] [Abstract][Full Text] [Related]
16. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
[TBL] [Abstract][Full Text] [Related]
17. Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
Voorter CE; van der Vlies S; Kik M; van den Berg-Loonen EM
Tissue Antigens; 2000 Oct; 56(4):363-70. PubMed ID: 11098937
[TBL] [Abstract][Full Text] [Related]
18. Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patient.
Lutz CT; Al-Attar A; May JR; Jennings CD
Transplantation; 2014 Oct; 98(8):853-6. PubMed ID: 24914571
[TBL] [Abstract][Full Text] [Related]
19. Specificity of two anti-class I HLA monoclonal antibodies that block class I recognition by the NKB1 killer cell inhibitory receptor.
Gumperz JE; Paterson JC; Litwin V; Valiante N; Lanier LL; Parham P; Little AM
Tissue Antigens; 1996 Oct; 48(4 Pt 1):278-84. PubMed ID: 8946681
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation: Improving alloreactive Bw4 donor selection by genotyping codon 86 of KIR3DL1/S1.
Alicata C; Pende D; Meazza R; Canevali P; Loiacono F; Bertaina A; Locatelli F; Nemat-Gorgani N; Guethlein LA; Parham P; Moretta L; Moretta A; Bottino C; Norman PJ; Falco M
Eur J Immunol; 2016 Jun; 46(6):1511-7. PubMed ID: 26990677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
